QAV680 [Ligand Id: 8996] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL2442750 (Nvp-qav-680, NVP-QAV680, Qav-680, Qav680, QAV680, Qav-690 free acid, QAV690 FREE ACID)
  • DP2 receptor/G protein-coupled receptor 44 in Human [ChEMBL: CHEMBL5071] [GtoPdb: 339] [UniProtKB: Q9Y5Y4]
  • DP2 receptor/G protein-coupled receptor 44 in Mouse [ChEMBL: CHEMBL2291] [GtoPdb: 339] [UniProtKB: Q9Z2J6]
There should be some charts here, you may need to enable JavaScript!
  • DP1 receptor/Prostanoid DP receptor in Human [ChEMBL: CHEMBL4427] [GtoPdb: 338] [UniProtKB: Q13258]
There should be some charts here, you may need to enable JavaScript!
  • EP2 receptor/Prostanoid EP2 receptor in Human [ChEMBL: CHEMBL1881] [GtoPdb: 341] [UniProtKB: P43116]
There should be some charts here, you may need to enable JavaScript!
  • EP3 receptor/Prostanoid EP3 receptor in Human [ChEMBL: CHEMBL3710] [GtoPdb: 342] [UniProtKB: P43115]
There should be some charts here, you may need to enable JavaScript!
  • EP4 receptor/Prostanoid EP4 receptor in Human [ChEMBL: CHEMBL1836] [GtoPdb: 343] [UniProtKB: P35408]
There should be some charts here, you may need to enable JavaScript!
  • FP receptor/Prostanoid FP receptor in Human [ChEMBL: CHEMBL1987] [GtoPdb: 344] [UniProtKB: P43088]
There should be some charts here, you may need to enable JavaScript!
  • IP receptor/Prostanoid IP receptor in Human [ChEMBL: CHEMBL1995] [GtoPdb: 345] [UniProtKB: P43119]
There should be some charts here, you may need to enable JavaScript!
  • TP receptor/Thromboxane A2 receptor in Human [ChEMBL: CHEMBL2069] [GtoPdb: 346] [UniProtKB: P21731]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
DP2 receptor/G protein-coupled receptor 44 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5071] [GtoPdb: 339] [UniProtKB: Q9Y5Y4]
ChEMBL Displacement of [3H]NVP-QAW039 from human DP2 receptor expressed in CHO cell membranes by TopCount scintillation assay B 7.82 pKd 15.14 nM Kd ACS Med Chem Lett (2017) 8: 582-586 [PMID:28523115]
GtoPdb - - 7.82 pKd 15.1 nM Kd Eur Respir J (2014) 44: 4074
ChEMBL Displacement of [3H]-prostaglandin D2 from human CRTh2 receptor expressed in CHO cells after 2 hrs B 7.44 pKi 36 nM Ki Bioorg Med Chem (2013) 21: 6582-6591 [PMID:24021582]
ChEMBL Displacement of [3H]PGD2 from human DP2 receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assay B 7.44 pKi 36 nM Ki ACS Med Chem Lett (2017) 8: 582-586 [PMID:28523115]
ChEMBL Displacement of [3H]-PGD2 from human CRTh2 expressed in CHO-K1 cell membranes incubated for 1 hr by SPA binding assay B 7.54 pKi 29 nM Ki US-7666878-B2. Pyrrolopyridine derivatives and their use as Crth2 antagonists (2010)
ChEMBL Antagonist activity at CRTh2 receptor in human isolated eosinophil assessed as inhibition of eotaxin-induced shape change after 5 mins by flow cytometry B 5 pIC50 >10000 nM IC50 Bioorg Med Chem (2013) 21: 6582-6591 [PMID:24021582]
ChEMBL Antagonist activity at CRTh2 receptor in human whole blood assessed as inhibition of PGD2-induced eosinophil shape change after 5 mins by flow cytometry B 6.99 pIC50 102 nM IC50 Bioorg Med Chem (2013) 21: 6582-6591 [PMID:24021582]
ChEMBL Antagonist activity at DP2 receptor in CD4-positive human TH2 cells assessed as inhibition of DK-PGD2-induced IL-5 production after 6 to 8 hrs B 7.23 pIC50 59 nM IC50 ACS Med Chem Lett (2017) 8: 582-586 [PMID:28523115]
ChEMBL Antagonist activity at human CRTh2 receptor expressed in CHO cells assessed as inhibition of prostaglandin D2 and forskolin-induced cAMP accumulation after 45 mins F 7.43 pIC50 37 nM IC50 Bioorg Med Chem (2013) 21: 6582-6591 [PMID:24021582]
ChEMBL Antagonist activity at CRTh2 receptor in human whole blood assessed as inhibition of DK-PGD2-induced eosinophil shape change after 5 mins by flow cytometry B 7.51 pIC50 31 nM IC50 Bioorg Med Chem (2013) 21: 6582-6591 [PMID:24021582]
ChEMBL Antagonist activity at DP2 receptor in human whole assessed as inhibition of DK-PGD2-induced eosinophils shape change preincubated for 5 mins followed by DK-PGD2 addition measured after 5 mins by flow cytometry B 7.51 pIC50 31 nM IC50 ACS Med Chem Lett (2017) 8: 582-586 [PMID:28523115]
ChEMBL Antagonist activity at DP2 receptor in CD4-positive human TH2 cells assessed as inhibition of DK-PGD2-induced IL-13 production after 6 to 8 hrs B 7.6 pIC50 25 nM IC50 ACS Med Chem Lett (2017) 8: 582-586 [PMID:28523115]
ChEMBL Antagonist activity against human CRTh2 expressed in CHO-K1 cells assessed as inhibition of PGD2-mediated attenuation of forskolin-induced cAMP accumulation incubated for 60 mins by scintillation counting method F 7.68 pIC50 21 nM IC50 US-7666878-B2. Pyrrolopyridine derivatives and their use as Crth2 antagonists (2010)
ChEMBL Antagonist activity at CRTh2 receptor in human isolated eosinophil assessed as inhibition of DK-PGD2-induced shape change after 5 mins by flow cytometry B 8.3 pIC50 5 nM IC50 Bioorg Med Chem (2013) 21: 6582-6591 [PMID:24021582]
ChEMBL Antagonist activity at DP2 receptor in human isolated eosinophils assessed as inhibition of DK-PGD2-induced shape change preincubated for 5 mins followed by DK-PGD2 addition measured after 5 mins by flow cytometry B 8.3 pIC50 5 nM IC50 ACS Med Chem Lett (2017) 8: 582-586 [PMID:28523115]
ChEMBL Antagonist activity at CRTh2 receptor in human isolated eosinophil assessed as inhibition of 11-Dehydro-TXB2-induced shape change after 5 mins by flow cytometry B 8.4 pIC50 4 nM IC50 Bioorg Med Chem (2013) 21: 6582-6591 [PMID:24021582]
ChEMBL Antagonist activity at CRTh2 receptor in human isolated eosinophil assessed as inhibition of delta12-PGD2-induced shape change after 5 mins by flow cytometry B 8.4 pIC50 4 nM IC50 Bioorg Med Chem (2013) 21: 6582-6591 [PMID:24021582]
ChEMBL Antagonist activity at CRTh2 receptor in human isolated eosinophil assessed as inhibition of delta12-PGJ2-induced shape change after 5 mins by flow cytometry B 8.52 pIC50 3 nM IC50 Bioorg Med Chem (2013) 21: 6582-6591 [PMID:24021582]
DP2 receptor/G protein-coupled receptor 44 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2291] [GtoPdb: 339] [UniProtKB: Q9Z2J6]
ChEMBL Displacement of [3H]-prostaglandin D2 from mouse CRTh2 receptor expressed in CHO cells after 2 hrs B 8 pKi 10 nM Ki Bioorg Med Chem (2013) 21: 6582-6591 [PMID:24021582]
ChEMBL Antagonist activity at mouse CRTh2 receptor expressed in CHO-K1 cells assessed as inhibition of [125S]-GTP-gamma-S binding after 50 mins by liquid scintillation counting F 7.03 pIC50 94 nM IC50 Bioorg Med Chem (2013) 21: 6582-6591 [PMID:24021582]
DP1 receptor/Prostanoid DP receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4427] [GtoPdb: 338] [UniProtKB: Q13258]
ChEMBL Inhibition of prostanoid DP1 receptor (unknown origin) B 5 pIC50 >10000 nM IC50 Bioorg Med Chem (2013) 21: 6582-6591 [PMID:24021582]
EP2 receptor/Prostanoid EP2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1881] [GtoPdb: 341] [UniProtKB: P43116]
ChEMBL Inhibition of prostanoid EP2 receptor (unknown origin) B 5 pIC50 >10000 nM IC50 Bioorg Med Chem (2013) 21: 6582-6591 [PMID:24021582]
EP3 receptor/Prostanoid EP3 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3710] [GtoPdb: 342] [UniProtKB: P43115]
ChEMBL Inhibition of prostanoid EP3 receptor (unknown origin) B 5 pIC50 >10000 nM IC50 Bioorg Med Chem (2013) 21: 6582-6591 [PMID:24021582]
EP4 receptor/Prostanoid EP4 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1836] [GtoPdb: 343] [UniProtKB: P35408]
ChEMBL Inhibition of prostanoid EP4 receptor (unknown origin) B 5 pIC50 >10000 nM IC50 Bioorg Med Chem (2013) 21: 6582-6591 [PMID:24021582]
FP receptor/Prostanoid FP receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1987] [GtoPdb: 344] [UniProtKB: P43088]
ChEMBL Inhibition of prostanoid FP receptor (unknown origin) B 5 pIC50 >10000 nM IC50 Bioorg Med Chem (2013) 21: 6582-6591 [PMID:24021582]
IP receptor/Prostanoid IP receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1995] [GtoPdb: 345] [UniProtKB: P43119]
ChEMBL Inhibition of prostanoid IP receptor (unknown origin) B 5 pIC50 >10000 nM IC50 Bioorg Med Chem (2013) 21: 6582-6591 [PMID:24021582]
TP receptor/Thromboxane A2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2069] [GtoPdb: 346] [UniProtKB: P21731]
ChEMBL Inhibition of prostanoid TP receptor (unknown origin) B 5 pIC50 >10000 nM IC50 Bioorg Med Chem (2013) 21: 6582-6591 [PMID:24021582]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]